GSK paid $85 million up front for global rights to a small-interfering RNA therapy discovered and developed by startup Empirico. The pharmaceutical giant said this

[Sponsored] Transitioning from military to civilian life can be overwhelming, especially for veterans facing mental health challenges, such as post-traumatic stress disorder (PTSD), depression or

Here are some key insights to help unlock the viability of PDTs to address unmet needs throughout the healthcare ecosystem — for patients and providers

[Sponsored] In interviews with MedCity News Reporter Marissa Plescia and Editor-in-Chief Arundhati Parmar, healthcare executives offered updates on their companies and their outlook. The post

Avidity Biosciences brings to Novartis three RNA therapies in pivotal testing for rare neuromuscular diseases along with the technology that produced them. This platform develops

At MedCity News’ Tête-à-tête Health event, executives from Sutter Health and Tampa General Hospital discussed how they are deploying AI, as well as how they